primary pulmonary hypertension

Exercise-induced pulmonary hypertension common in systemic sclerosis - Medicexchange (Primary Pulmonary Hypertension News)

August 7th, 2008


Exercise-induced pulmonary hypertension common in systemic sclerosis
Medicexchange, UK - 2 hours ago
Pulmonary arterial hypertension (PAH) can often become apparent during exercise testing in patients with systemic sclerosis, according to a report in the

Read More…


dBTechno

Uninsured And Chronically ill: The New American Health Risk
The Money Times, India - Aug 5, 2008
ambit of the study include cardiovascular disease, hypertension, diabetes, asthma, high cholesterol, chronic obstructive pulmonary disease and cancer.
One-Third of Uninsured Are Chronically Ill U.S. News & World Report
Chronic conditions afflict millions of uninsured adults McKnight’s Long Term Care News
google news commentComment by Karen Davis, Ph.D. President, The Commonwealth Fund
all 39 news articles

Read More…


2008 Leadership Summit under way at GBUMC
Gulf Breeze News,  USA - 17 hours ago
In 2004, Thompson was diagnosed with Lupus and severe pulmonary hypertension that is stressing her lungs, liver and heart. Lupus is an autoimmune disease

Read More…


EPIX Pharmaceuticals Secures Committed Equity Financing Facility
MarketWatch - Aug 5, 2008
expect to commence our Phase 2b trial for PRX-08066 for the treatment of pulmonary hypertension associated with chronic obstructive pulmonary disease.

Read More…


The FDA's Black Box
Forbes, NY - 3 hours ago
three "approvable" letters from the FDA requesting more study on a drug to treat a rare disease called pulmonary hypertension, the last in 2007.

Read More…

Posted in primary pulmonary hypertension | No Comments »


EU Extends Indication of Bosentan to Pulmonary Arterial … - DG News (Primary Pulmonary Hypertension News)

August 6th, 2008


EU Extends Indication of Bosentan to Pulmonary Arterial
DG News - 10 hours ago
for the treatment of patients with mildly symptomatic pulmonary arterial hypertension (PAH World Health Organization [WHO] functional class [FC] II).

Read More…


WKU To Induct Three Into Hall Of Distinguished Alumni
Amplifier, KY - 3 hours ago
Sharron H. Francisfrancis for her role in research that led to development of drugs to treat erectile dysfunction and pulmonary arterial hypertension.

Read More…


Vivus Pockets $65M and Kingsbridge Proffers $60M to Acadia as well
Genetic Engineering News (press release), NY - Aug 5, 2008
expect to commence our Phase 2b trial for PRX-08066 for the treatment of pulmonary hypertension associated with chronic obstructive pulmonary disease.”

Read More…


dBTechno

Uninsured And Chronically ill: The New American Health Risk
The Money Times, India - Aug 5, 2008
ambit of the study include cardiovascular disease, hypertension, diabetes, asthma, high cholesterol, chronic obstructive pulmonary disease and cancer.
One-Third of Uninsured Are Chronically Ill U.S. News & World Report
Chronic conditions afflict millions of uninsured adults McKnight’s Long Term Care News
google news commentComment by Karen Davis, Ph.D. President, The Commonwealth Fund
all 39 news articles

Read More…

Posted in primary pulmonary hypertension | No Comments »


EU Extends Indication of Bosentan to Pulmonary Arterial … - DG News (Primary Pulmonary Hypertension News)

August 6th, 2008


EU Extends Indication of Bosentan to Pulmonary Arterial
DG News - 10 hours ago
for the treatment of patients with mildly symptomatic pulmonary arterial hypertension (PAH World Health Organization [WHO] functional class [FC] II).

Read More…


Endothelin Antagonist Trial in Mildly Symptomatic Pulmonary
Medscape (subscription) - Jul 31, 2008
Pulmonary arterial hypertension (PAH) is characterized by progressive pulmonary arterial vasoconstriction and remodeling, leading to a marked rise in

Read More…

Posted in primary pulmonary hypertension | No Comments »


One-Third of Uninsured Are Chronically Ill - U.S. News & World Report (Primary Pulmonary Hypertension News)

August 5th, 2008


One-Third of Uninsured Are Chronically Ill
U.S. News & World Report, DC - 16 hours ago
Other conditions examined were asthma, high cholesterol, chronic obstructive pulmonary disease or a previous diagnosis of cancer.

Read More…


Sleep well
Southtown Star, IL - 4 hours ago
Now Sahloul is trying to help people rest easy at the new Southwest Sleep Center and Pulmonary Consultants in Oak Lawn. According to Sahloul, a sleep

Read More…


Tracleer(R) (bosentan) receives EU approval for treatment of
FOXBusiness - 23 hours ago
Survival in patients with primary pulmonary hypertension: Results from a national prospective registry. Ann Intern Med 1991;115:343-349.

Read More…


Tracleer(R) (bosentan) Receives EU Approval For Treatment Of
Medical News Today (press release), UK - Aug 4, 2008
The primary endpoints for the EARLY trial were changes in pulmonary vascular resistance (PVR) and exercise capacity as measured by a 6-minute walk test

Read More…

Posted in primary pulmonary hypertension | No Comments »


Tracleer(R) (bosentan) Receives EU Approval For Treatment Of … - Medical News Today (press release) (Primary Pulmonary Hypertension News)

August 4th, 2008


Tracleer(R) (bosentan) Receives EU Approval For Treatment Of
Medical News Today (press release), UK - 15 hours ago
The primary endpoints for the EARLY trial were changes in pulmonary vascular resistance (PVR) and exercise capacity as measured by a 6-minute walk test
Tracleer® (bosentan) receives EU approval for treatment of Ad-Hoc-News (Pressemitteilung)
all 8 news articles

Read More…


Health Happenings
Fort Worth Star Telegram, TX - 4 hours ago
COPD (chronic obstructive pulmonary disease) Support Group, for pulmonary patients and their families, meets at 1:30 pm the first Tuesday of the month at

Read More…


A National Study of Chronic Disease Prevalence and Access to Care
Annals of Internal Medicine - 2 hours ago
hypertension, diabetes, hypercholesterolemia, active asthma or chronic obstructive pulmonary disease, previous cancer, and measures of access to care.

Read More…


One-Third of Uninsured Are Chronically Ill
U.S. News & World Report, DC - 3 hours ago
Other conditions examined were asthma, high cholesterol, chronic obstructive pulmonary disease or a previous diagnosis of cancer.

Read More…


Planned R&D Hike Gives Gilead Investors Pause
TMCnet - 1 hour ago
The company also is pushing forward with cicletanine, a once-daily oral agent in pulmonary arterial hypertension (PAH) and recently started a Phase IV trial

Read More…

Posted in primary pulmonary hypertension | No Comments »


Edmond teen fights back - Edmond Sun (Primary Pulmonary Hypertension News)

August 3rd, 2008


Edmond teen fights back
Edmond Sun, OK - Aug 1, 2008
EDMOND — Lauren Johnson, 16, looks like a normal teenager on the outside but daily fights the symptoms of a disease called pulmonary hypertension,

Read More…


Lung transplant recipient recovering
Dubuque Telegraph Herald, IA - Jul 31, 2008
Tuesday's procedure was Nick's second transplant. A rare lung ailment called primary pulmonary hypertension led to his first transplant a decade ago.

Read More…


Endothelin Antagonist Trial in Mildly Symptomatic Pulmonary
Medscape (subscription) - Jul 31, 2008
Pulmonary arterial hypertension (PAH) is characterized by progressive pulmonary arterial vasoconstriction and remodeling, leading to a marked rise in

Read More…


Dubuque boy undergoes transplant
Dubuque Telegraph Herald, IA - Jul 30, 2008
A rare lung ailment called primary pulmonary hypertension led to his first transplant a decade ago. Doctors had hoped the first transplanted lungs would

Read More…

Posted in primary pulmonary hypertension | No Comments »


Support Groups - Eagle Tribune (Primary Pulmonary Hypertension News)

August 3rd, 2008


Support Groups
Eagle Tribune, MA - 1 hour ago
Anyone interested in learning more about scleroderma and pulmonary hypertension is welcome. For more information, call Pat Gelinas at 329-8382 or the

Read More…


First half 2008 financial results: NicOx nears completion of phase
FOXBusiness - Jul 28, 2008
The two studies have recruited a total of 417 osteoarthritis patients with controlled hypertension and results are projected in the fourth quarter of 2008.

Read More…


HomeCARE II: BIOTRONIK Launches Clinical Study Using Inovative
Medical News Today (press release), UK - 16 hours ago
Many heart failure patients have pulmonary congestion. The new sensor technology will continuously monitor lung fluid levels (intrathoracic impedance) in

Read More…

Posted in primary pulmonary hypertension | No Comments »


New Eloxatin(R) and Taxotere(R) Data in Several Tumor Types to Be - PR Newswire (Primary Pulmonary Hypertension News)

August 2nd, 2008

- 430 abstracts from studies involving Taxotere(R) or Eloxatin(R) accepted at the meeting’s scientific sessions - BRIDGEWATER, N.J., May 31 /PRNewswire-FirstCall/ — Sanofi-aventis U.S. announced today that key study results from the company’s Read More

Background: In 1999, the country began a political, legal, economical and social transition process with the objective to initiate a new development model that strengthens the democratic system. The political transition has allowed the writing of the Read More

Pulmonary arterial hypertension (PAH) is characterized by progressive pulmonary arterial vasoconstriction and remodeling, leading to a marked rise in pulmonary vascular resistance (PVR), pulmonary hypertension, right ventricular dysfunction Read More

Physicians face a daunting task in achieving and maintaining competence in drug therapy. Essential underpinnings of rational drug therapy that are taught in medical school, including physiology, pharmacokinetics, and pharmacodynamics, are all too Read More

IRVINE, Calif., Feb. 20 /PRNewswire/ — LifeMasters Supported SelfCare, Inc., a national provider of health improvement services, announced that it has received an extension from the Centers for Medicare & Medicaid Services (CMS) of its disease Read More

Posted in primary pulmonary hypertension | No Comments »


Financial Results for Full Year 2007: NicOx Significantly Advances - PR Newswire (Primary Pulmonary Hypertension News)

July 31st, 2008

SOPHIA ANTIPOLIS, France, March 3 /PRNewswire-FirstCall/ — NicOx S.A. Euronext: COX Paris: COX today announced its financial results for 2007 and provided an overview of its activities during the year. NicOx also announced today the initiation of Read More

CHICAGO, July 29, 2008 – Elan Corporation, plc (NYSE: ELN) and Wyeth (NYSE: WYE) today are presenting detailed results from the companies’ 18-month Phase 2 study of bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer’s disease at Read More

Elan Corporation, plc ELN and Wyeth WYE today are presenting detailed results from the companies ’ 18-month Phase 2 study of bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer’s disease at the Alzheimer ’ s Association ’ s Read More

Posted in primary pulmonary hypertension | No Comments »


Elan and Wyeth Present Encouraging Results from Phase 2 Clinical Trial - MSN MoneyCentral (Primary Pulmonary Hypertension News)

July 31st, 2008

Elan Corporation, plc ELN and Wyeth WYE today are presenting detailed results from the companies ’ 18-month Phase 2 study of bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer’s disease at the Alzheimer ’ s Association ’ s Read More

IRVINE, Calif., Feb. 20 /PRNewswire/ — LifeMasters Supported SelfCare, Inc., a national provider of health improvement services, announced that it has received an extension from the Centers for Medicare & Medicaid Services (CMS) of its disease Read More

Posted in primary pulmonary hypertension | No Comments »